Chemex Global Opens API Plant in Guwahati

India Pharma Outlook Team | Monday, 26 February 2024

 pharmaceutical ecosystem, healthcare solutions, India Pharma Outlook

Photo:Representative Image

Chemex Global, a research-driven pharmaceutical company, has opened its first Active Pharmaceutical Ingredients (API) manufacturing facility in Guwahati, Assam. This cutting-edge plant is the first of its kind in the Northeast region of India and marks a significant milestone for the pharmaceutical industry.

Equipped with advanced technology and staffed by a highly skilled workforce, the Chemex Global API plant will produce essential ingredients for a wide range of pharmaceutical products. With its state-of-the-art R&D lab and bulk production facility, Chemex Global will meet the growing demand for high-quality APIs in India and beyond.

The inauguration of the Chemex Global API plant is expected to create over 200 new jobs and help develop a robust regional pharmaceutical ecosystem. Assam's strategic location and improved connectivity make it an ideal hub for pharmaceutical manufacturing and trade with Southeast Asia.

Chemex Global's commitment to sustainable manufacturing is evident in the plant's design and operations. The facility uses energy-efficient technologies and adheres to the highest environmental standards.

By investing in this plant, Chemex Global demonstrates its confidence in the potential of the Northeast region and its dedication to providing affordable and accessible healthcare solutions to the people of India and beyond.

© 2024 India Pharma Outlook. All Rights Reserved.